<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>PACIRA PHARMACEUTICALS RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Börsengeschehen</description><category>Finanzen</category><link>https://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><lastBuildDate>Sun, 12 Apr 2026 06:30:43 +0200</lastBuildDate><atom:link href="https://www.finanzen.net/rss/pacira%5Fpharmaceuticals%2Drss%2Dfeed" rel="self" type="application/rss+xml"/><image><url>https://images.finanzen.net/images/finanzen_net_neu.gif</url><title>PACIRA PHARMACEUTICALS RSS Feed | Nachrichten - www.finanzen.net</title><link>https://www.finanzen.net</link></image><item><title>Pacira Pharmaceuticals präsentierte Bilanzzahlen zum jüngsten Jahresviertel</title><pubDate>Sun, 01 Mar 2026 06:35:06 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/pacira-pharmaceuticals-praesentierte-bilanzzahlen-zum-juengsten-jahresviertel-15525519</link><description><![CDATA[<p><a href="https://www.finanzen.net/aktien/pacira_pharmaceuticals-aktie">Pacira Pharmaceuticals</a> lud am 26.02.2026 zur turnusmäßigen Finanzkonferenz und hat dort das Zahlenwerk zum jüngsten Quartal veröffentlicht, das am 31.12.2025 endete.Das EPS belief sich auf 0,04 USD gegenüber  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/pacira-pharmaceuticals-praesentierte-bilanzzahlen-zum-juengsten-jahresviertel-15525519</guid></item><item><title>DOMA Perpetual Capital Management Announces Intent to Nominate Three Highly Qualified, Independent Director Candidates at 2026 Annual Meeting of Pacira BioSciences, Inc.</title><pubDate>Tue, 30 Dec 2025 16:41:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/doma-perpetual-capital-management-announces-intent-to-nominate-three-highly-qualified-independent-director-candidates-at-2026-annual-meeting-of-pacira-biosciences-inc-15385305</link><description><![CDATA[<p><p class="prntac" xmlns="http://www.w3.org/1999/xhtml"><b><i>Restates Position that Pacira's Board Should Conduct Formal Sales Process of the Business</i></b><p class="prntac" xmlns="http://www.w3.org/1999/xhtml"><b><i>Considers Current Executive Compensation  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/doma-perpetual-capital-management-announces-intent-to-nominate-three-highly-qualified-independent-director-candidates-at-2026-annual-meeting-of-pacira-biosciences-inc-15385305</guid></item><item><title>DOMA Perpetual Sends Letter Calling for the Board of Directors of Pacira BioSciences, Inc. to Immediately Explore a Sale of the Business</title><pubDate>Tue, 11 Nov 2025 02:09:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/doma-perpetual-sends-letter-calling-for-the-board-of-directors-of-pacira-biosciences-inc-to-immediately-explore-a-sale-of-the-business-15256170</link><description><![CDATA[<p><a href="https://mma.prnewswire.com/media/2468496/DOMA_PERPETUAL___Logo.html" target="_blank" rel="nofollow"><img src="https://mma.prnewswire.com/media/2468496/DOMA_PERPETUAL___Logo.jpg" title="(PRNewsfoto/DOMA Perpetual)" alt="(PRNewsfoto/DOMA Perpetual)"></a><p  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/doma-perpetual-sends-letter-calling-for-the-board-of-directors-of-pacira-biosciences-inc-to-immediately-explore-a-sale-of-the-business-15256170</guid></item><item><title>Pacira Pharmaceuticals veröffentlichte Zahlen zum vergangenen Quartal</title><pubDate>Sun, 09 Nov 2025 06:35:07 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/pacira-pharmaceuticals-veroeffentlichte-zahlen-zum-vergangenen-quartal-15236025</link><description><![CDATA[<p><a href="https://www.finanzen.net/aktien/pacira_pharmaceuticals-aktie">Pacira Pharmaceuticals</a> hat am 06.11.2025 das Zahlenwerk zum am 30.09.2025 abgelaufenen Jahresviertel vorgestellt.Für das jüngste Quartal wurde eine Gewinn je Aktie von 0,12 USD ausgewiesen. Im Vorjahresviertel  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/pacira-pharmaceuticals-veroeffentlichte-zahlen-zum-vergangenen-quartal-15236025</guid></item><item><title>Canadian Investment Regulatory Organization Trade Resumption - PCRX</title><pubDate>Thu, 06 Nov 2025 13:55:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/canadian-investment-regulatory-organization-trade-resumption-pcrx-15207482</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="xn-location">VANCOUVER, BC, <span class="legendSpanClass"><span class="xn-chron">Nov. 6, 2025 /CNW/ - Trading resumes in:<p xmlns="http://www.w3.org/1999/xhtml">Company: PharmaCorp Rx Inc.<p xmlns="http://www.w3.org/1999/xhtml">TSX-Venture  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/canadian-investment-regulatory-organization-trade-resumption-pcrx-15207482</guid></item><item><title>Canadian Investment Regulatory Organization Trade Resumption - PCRX</title><pubDate>Thu, 06 Nov 2025 13:55:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/canadian-investment-regulatory-organization-trade-resumption-pcrx-15207484</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="xn-location">VANCOUVER, BC, <span class="legendSpanClass"><span class="xn-chron">Nov. 6, 2025 /CNW/ - Trading resumes in:<p xmlns="http://www.w3.org/1999/xhtml">Company: PharmaCorp Rx Inc.<p xmlns="http://www.w3.org/1999/xhtml">TSX-Venture  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/canadian-investment-regulatory-organization-trade-resumption-pcrx-15207484</guid></item><item><title>Canadian Investment Regulatory Organization Trading Halt  - PCRX</title><pubDate>Wed, 05 Nov 2025 22:50:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/canadian-investment-regulatory-organization-trading-halt-pcrx-15200554</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="xn-location">VANCOUVER, BC, <span class="legendSpanClass"><span class="xn-chron">Nov. 5, 2025 /CNW/ - The following issues have been halted by CIRO:<p xmlns="http://www.w3.org/1999/xhtml">Company: PharmaCorp  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/canadian-investment-regulatory-organization-trading-halt-pcrx-15200554</guid></item><item><title>Canadian Investment Regulatory Organization Trading Halt  - PCRX</title><pubDate>Wed, 05 Nov 2025 22:50:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/canadian-investment-regulatory-organization-trading-halt-pcrx-15200555</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="xn-location">VANCOUVER, BC, <span class="legendSpanClass"><span class="xn-chron">Nov. 5, 2025 /CNW/ - The following issues have been halted by CIRO:<p xmlns="http://www.w3.org/1999/xhtml">Company: PharmaCorp  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/canadian-investment-regulatory-organization-trading-halt-pcrx-15200555</guid></item></channel></rss>
